Publications for John F. Modlin, MD https://geiselmed.dartmouth.edu/faculty/facultydb/view.php?uid=1375 Publications for John F. Modlin, MD en-us <![CDATA[Intestinal Mucosal Immune Responses to Novel Oral Poliovirus Vaccine Type 2 in Healthy Newborns.]]> https://www.ncbi.nlm.nih.gov/pubmed/40907970 Clin Infect Dis. 2026 Feb 25;82(2):e352-e360. doi: 10.1093/cid/ciaf484.
PMID: 40907970]]> <![CDATA[Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials.]]> https://www.ncbi.nlm.nih.gov/pubmed/40318674 Lancet Microbe. 2025 Jun;6(6):101028. doi: 10.1016/j.lanmic.2024.101028. Epub 2025 Apr 30.
PMID: 40318674]]> <![CDATA[Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional study.]]> https://www.ncbi.nlm.nih.gov/pubmed/40037127 Vaccine. 2025 Apr 19;53:126936. doi: 10.1016/j.vaccine.2025.126936. Epub 2025 Mar 3.
PMID: 40037127]]> <![CDATA[Nasal and Pharyngeal Mucosal Immunity to Poliovirus in Children Following Routine Immunization With Inactivated Polio Vaccine in the United States.]]> https://www.ncbi.nlm.nih.gov/pubmed/38809190 J Infect Dis. 2024 Nov 15;230(5):e1023-e1030. doi: 10.1093/infdis/jiae264.
PMID: 38809190]]> <![CDATA[Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.]]> https://www.ncbi.nlm.nih.gov/pubmed/34590135 J Infect Dis. 2021 Sep 30;224(12 Suppl 2):S398-S404. doi: 10.1093/infdis/jiaa622.
PMID: 34590135]]> <![CDATA[Mucosal immunity to poliovirus.]]> https://www.ncbi.nlm.nih.gov/pubmed/34239028 Mucosal Immunol. 2022 Jan;15(1):1-9. doi: 10.1038/s41385-021-00428-0. Epub 2021 Jul 8.
PMID: 34239028]]> <![CDATA[Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.]]> https://www.ncbi.nlm.nih.gov/pubmed/33308429 Lancet. 2021 Jan 2;397(10268):39-50. doi: 10.1016/S0140-6736(20)32541-1. Epub 2020 Dec 9.
PMID: 33308429]]> <![CDATA[Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.]]> https://www.ncbi.nlm.nih.gov/pubmed/33308427 Lancet. 2021 Jan 2;397(10268):27-38. doi: 10.1016/S0140-6736(20)32540-X. Epub 2020 Dec 9.
PMID: 33308427]]> <![CDATA[Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden.]]> https://www.ncbi.nlm.nih.gov/pubmed/31543993 BMJ Glob Health. 2019;4(4):e001613. doi: 10.1136/bmjgh-2019-001613. Epub 2019 Aug 28.
PMID: 31543993]]> <![CDATA[Progress in the development of poliovirus antiviral agents and their essential role in reducing risks that threaten eradication.]]> https://www.ncbi.nlm.nih.gov/pubmed/25316866 J Infect Dis. 2014 Nov 1;210 Suppl 1:S447-53. doi: 10.1093/infdis/jiu043.
PMID: 25316866]]>